Evolear Past Earnings Performance
Past criteria checks 0/6
Evolear has been growing earnings at an average annual rate of 24.8%, while the Medical Equipment industry saw earnings growing at 21.2% annually. Revenues have been declining at an average rate of 32.4% per year.
Key information
24.8%
Earnings growth rate
59.7%
EPS growth rate
| Medical Equipment Industry Growth | 6.2% |
| Revenue growth rate | -32.4% |
| Return on equity | -234.2% |
| Net Margin | -257.0% |
| Next Earnings Update | 15 Nov 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Evolear makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 2 | -6 | 1 | 0 |
| 31 Mar 24 | 2 | -5 | 1 | 0 |
| 31 Dec 23 | 2 | -4 | 1 | 0 |
| 30 Sep 23 | 2 | -3 | 1 | 0 |
| 30 Jun 23 | 1 | -2 | 0 | 0 |
| 31 Mar 23 | 1 | -1 | 0 | 0 |
| 31 Dec 22 | 0 | 0 | 0 | 0 |
| 30 Sep 22 | -6 | 10 | -13 | 0 |
| 30 Jun 22 | -3 | 7 | -9 | 0 |
| 31 Mar 22 | -2 | 2 | -4 | 0 |
| 31 Dec 21 | 0 | 0 | 0 | 0 |
| 30 Sep 21 | 10 | -11 | 19 | 0 |
| 30 Jun 21 | 11 | -5 | 14 | 0 |
| 31 Mar 21 | 11 | -9 | 18 | 0 |
| 31 Dec 20 | 11 | -8 | 18 | 0 |
| 30 Sep 20 | 9 | -8 | 16 | 0 |
| 30 Jun 20 | 6 | -14 | 19 | 0 |
| 31 Mar 20 | 6 | -7 | 12 | 0 |
| 31 Dec 19 | 5 | -7 | 11 | 0 |
| 30 Sep 19 | 5 | -5 | 9 | 0 |
| 30 Jun 19 | 4 | -4 | 8 | 0 |
| 31 Mar 19 | 4 | -3 | 6 | 0 |
| 31 Dec 18 | 3 | -3 | 6 | 0 |
| 30 Sep 18 | 2 | -3 | 5 | 0 |
| 30 Jun 18 | 3 | -2 | 5 | 0 |
| 31 Mar 18 | 2 | -2 | 4 | 0 |
| 31 Dec 17 | 2 | -2 | 4 | 0 |
| 31 Dec 16 | 2 | 5 | 3 | 0 |
| 31 Dec 15 | 2 | -3 | 4 | 0 |
| 31 Dec 14 | 2 | -3 | 4 | 0 |
Quality Earnings: EVOL is currently unprofitable.
Growing Profit Margin: EVOL is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: EVOL is unprofitable, but has reduced losses over the past 5 years at a rate of 24.8% per year.
Accelerating Growth: Unable to compare EVOL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: EVOL is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (28.2%).
Return on Equity
High ROE: EVOL has a negative Return on Equity (-234.22%), as it is currently unprofitable.